NEUROLOGY 2006;67:716-718
© 2006 American Academy of Neurology
Brief Communications
Do carriers of PYGM mutations have symptoms of McArdle disease?
Susanne Tvede Andersen, MD,
Morten Dunø, PhD,
Marianne Schwartz, PhD and
John Vissing, MD, PhD
From the Neuromuscular Research Unit, Department of Neurology, and the Copenhagen Muscle Research Center (S.T.A., J.V.); and Department of Clinical Genetics (M.D., M.S.) National University Hospital, Rigshospitalet, Copenhagen, Denmark.
Address correspondence and reprint requests to Dr. John Vissing, Department of Neurology, 2082 National University Hospital, Rigshospitalet Blegdamsvej 9, DK-2100 Copenhagen, Denmark; e-mail: vissing{at}rh.dk
The authors investigated whether carriers of single myophosphorylase gene (PYGM) mutations have symptoms of McArdle disease. They studied the oxidative capacity and lactate responses to maximal cycle exercise in eight patients with McArdle disease, seven single PYGM mutation carriers, and 11 healthy subjects. Heterozygotes had maximal oxidative capacity and peak lactate responses identical to control subjects. Thus, carriers of single PYGM mutations are not prone to develop symptoms of McArdle disease.
Supported by grants from the NOVO Nordic Foundation, the University of Copenhagen, and the Copenhagen Hospital Corporation.
Disclosure: The authors report no conflicts of interest.
Received February 8, 2006. Accepted in final form April 19, 2006.
This article has been cited by other articles:

|
 |

|
 |
 
S. T. Andersen, T. D. Jeppesen, T. Taivassalo, M.-L. Sveen, K. Heinicke, R. G. Haller, and J. Vissing
Effect of Changes in Fat Availability on Exercise Capacity in McArdle Disease
Arch Neurol,
June 1, 2009;
66(6):
762 - 766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vissing, M. Duno, M. Schwartz, and R. G. Haller
Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease
Brain,
June 1, 2009;
132(6):
1545 - 1552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Naini, A. Toscano, O. Musumeci, J. Vissing, H. O. Akman, and S. DiMauro
Muscle Phosphoglycerate Mutase Deficiency Revisited
Arch Neurol,
March 1, 2009;
66(3):
394 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Garcia-Consuegra, J C Rubio, G Nogales-Gadea, J Bautista, S Jimenez, A Cabello, A Lucia, A L Andreu, J Arenas, and M A Martin
Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA
J. Med. Genet.,
March 1, 2009;
46(3):
198 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S T Andersen and J Vissing
Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity
J. Neurol. Neurosurg. Psychiatry,
December 1, 2008;
79(12):
1359 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Andersen, R. G. Haller, and J. Vissing
Effect of Oral Sucrose Shortly Before Exercise on Work Capacity in McArdle Disease
Arch Neurol,
June 1, 2008;
65(6):
786 - 789.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|